DrugDev Selected for TransCelerate's Investigator Registry

February 23, 2015
Applied Clinical Trials Editorial Staff

Applied Clinical Trials

TransCelerate BioPharma Inc. has selected DrugDev to develop and host its Investigator Registry

TransCelerate BioPharma Inc. has selected DrugDev to develop and host its Investigator Registry, which will allow TransCelerate member companies to pool investigator data together into a centralized, cloud-based resource utilizing a universal identifier known as the DrugDev Golden Number. The registry, along with TransCelerate’s Shared Investigator Platform, will help streamline some of the more inefficient clinical trial processes by offering the ability to expeditiously find investigator matches for their trials will drive improved performance.

For investigators, the registry expands their access to clinical trial opportunities by making them known throughout participating TransCelerate Member Companies. Moreover, making their investigator and site profile information available in the registry reduces the number of basic site information requests, which in turn allows them to spend more time focused on clinical activities.

DrugDev also is the third party host of the Investigator Databank.

Read the full release here.

Related Content:

News